Microneedle coronavirus vaccine triggers immune response in mice

When delivered to mice using microneedles, an experimental vaccine for COVID-19 caused antibody production against the disease.

COVID-19 is an emerging, rapidly evolving situation, and we at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines. You can find the latest public health information from CDC at www.coronavirus.gov and the latest research information from NIH at www.nih.gov/coronavirus. Because of the subject matter, we are posting this story in advance for the April 14 edition of NIH Research Matters: Microneedle coronavirus vaccine triggers immune response in mice When delivered to mice using microneedles, an experimental vaccine for COVID-19 caused antibody production against the disease within two weeks. Popular Stories Novel coronavirus structure reveals targets for vaccines and treatments Study suggests new coronavirus may remain on surfaces for days How stress causes gray hair Number of steps per day more important than step intensity New blood test method may predict Alzheimer's disease Connect with Us Facebook RSS Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health. NIH…Turning Discovery Into Health®      This email was sent to ymilov@gmail.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612